[go: up one dir, main page]

GB0625194D0 - Methods - Google Patents

Methods

Info

Publication number
GB0625194D0
GB0625194D0 GB0625194A GB0625194A GB0625194D0 GB 0625194 D0 GB0625194 D0 GB 0625194D0 GB 0625194 A GB0625194 A GB 0625194A GB 0625194 A GB0625194 A GB 0625194A GB 0625194 D0 GB0625194 D0 GB 0625194D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0625194A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Theragenetics Ltd
Original Assignee
KCL ENTPR Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KCL ENTPR Ltd filed Critical KCL ENTPR Ltd
Priority to GB0625194A priority Critical patent/GB0625194D0/en
Publication of GB0625194D0 publication Critical patent/GB0625194D0/en
Priority to US12/002,839 priority patent/US20090042194A1/en
Priority to PCT/US2007/025940 priority patent/WO2008076449A2/en
Priority to PCT/US2007/025858 priority patent/WO2008076434A2/en
Priority to US12/002,875 priority patent/US20080206768A1/en
Priority to US12/798,790 priority patent/US20110223593A1/en
Priority to US12/798,789 priority patent/US20110287417A1/en
Ceased legal-status Critical Current

Links

GB0625194A 2006-12-18 2006-12-18 Methods Ceased GB0625194D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB0625194A GB0625194D0 (en) 2006-12-18 2006-12-18 Methods
US12/002,839 US20090042194A1 (en) 2006-12-18 2007-12-18 Predicting a response to risperidone
PCT/US2007/025940 WO2008076449A2 (en) 2006-12-18 2007-12-18 Predicting a response to olanzapine
PCT/US2007/025858 WO2008076434A2 (en) 2006-12-18 2007-12-18 Predicting a response to risperidone
US12/002,875 US20080206768A1 (en) 2006-12-18 2007-12-18 Predicting a response to olanzapine
US12/798,790 US20110223593A1 (en) 2006-12-18 2010-04-09 Predicting a response to olanzapine
US12/798,789 US20110287417A1 (en) 2006-12-18 2010-04-09 Predicting a response to risperidone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0625194A GB0625194D0 (en) 2006-12-18 2006-12-18 Methods

Publications (1)

Publication Number Publication Date
GB0625194D0 true GB0625194D0 (en) 2007-01-24

Family

ID=37712323

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0625194A Ceased GB0625194D0 (en) 2006-12-18 2006-12-18 Methods

Country Status (1)

Country Link
GB (1) GB0625194D0 (en)

Similar Documents

Publication Publication Date Title
DE602007002700D1 (en) Interventionsfreies frac-system
EP2078282A4 (en) E-couponing
DE602007008085D1 (en) Dihydropyrazolopyrimidinonderivate
DE602007014031D1 (en) Luftreifensatz
DE602007002070D1 (en) 2-pyrazincarboxamidderivate
DE602007001601D1 (en) Glasuntersuchung
EP1983992A4 (en) 2-imino-benzimidazoles
DE602007003855D1 (en) Isothermer reaktor
DE602007006989D1 (en) Spiropiperidinderivate
EP2084019A4 (en) Paintscraper
AP2008004724A0 (en) Substituted1-yl)-azolin-2-aryl-1-hetaryl-ethane
DE602007011622D1 (en) Penem-prodrugs
EP2024567A4 (en) Earthen-wallpaper
GB0613209D0 (en) Methods
GB0600967D0 (en) Methods
EP2007388A4 (en) Opiopathies
EP2115136A4 (en) Novel methods
GB0608941D0 (en) Methods
DK1989111T3 (en) Satellitluftbremseapparat
GB0607377D0 (en) Novel Methods
EP1974618A4 (en) Innerwear
DE502007001126D1 (en) Eiten
GB0624391D0 (en) Methods
GB0606198D0 (en) Methods
GB0606432D0 (en) Methods

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: THERAGENETICS LIMITED

Free format text: FORMER APPLICANT(S): KINGS COLLEGE LONDON

AT Applications terminated before publication under section 16(1)